Ozempic linked to lower Alzheimer’s risk in people with Type 2 diabetes

Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes, according to a study published Thursday in the journal Alzheimer’s & Dementia.

Leave a Reply

Your email address will not be published. Required fields are marked *